期刊文献+

子宫内膜癌的MRI动态增强特征 被引量:11

The Characteristics of Dynamic Contrast-enhanced MRI in Endometrial Carcinoma
下载PDF
导出
摘要 目的探讨子宫内膜癌DCE-MRI的特征,为多期增强扫描的时相选择提供参考。方法选取17例术后病理证实为子宫内膜癌Ⅰ-Ⅱ期的患者作为病例组,对照组为4例子宫体部子宫肌瘤和8名女性志愿者,术前均行常规MRI平扫、DCEMRI扫描,选取感兴趣区域绘制增强的时间-信号强度曲线(TIC),计算各感兴趣区域在增强30s、60s、120s、150s时相的强化率(E),用student-t检验分析各时相强化率的差异;分析两者的时间-信号强度曲线(TIC)的特征。结果子宫内膜癌在增强早期轻度强化,与正常子宫肌层强化率的差异无统计学意义(P>0.05),与子宫肌瘤强化率的差异有统计学意义(P<0.05),增强中晚期(30-150s)子宫内膜癌强化率与对照组均有差异(P<0.05)。子宫内膜癌与正常肌层差异在晚期(120-150s)最大,与子宫肌瘤组差异在增强早期末段(20-30s)最大。17例子宫内膜癌,其中15例TIC呈Ⅰ型,2例TIC呈Ⅱ型;对照组TIC绝大部分呈Ⅲ、Ⅳ、Ⅴ型。结论 DCE-MRI能反映子宫内膜癌血流动力学变化,结合TIC,重点观察中晚期(60-150s)时间段内子宫内膜癌信号变化及强化率,有助子宫内膜癌的诊断及分期。 Objective To explore The characteristics of dynamic contrast-enhanced MRI(DEC-MRI) in endometrial carcinoma, to provide reference to nmlti-phase contrast-enhanced scan. Methods Seventeen cases with endometrial carcinoma in stage Ⅰ to Ⅱ proved pathologically were served as study group, 4 cases with hysteromyoma in uterine body and 8 volunteers as control group. Plain scan and dynamic contrast-enhanced MR scan were underwent to the patients in the study group as well as the volunteers in the control group. ROI was selected and the time-intensity curve(TIC) was drawn from the DEC-MRI of ROl, ROI enhanced rate(E) were calculated respectively in 30s, 60s, 90s, 150s. Then we analyzed the differences of enhanced rate respectively with the student-test ( P〈0.05 ) between the study group and control group. Then we analyzed their TIC characteristics. Results All endometrial carcinomas showed slightly contrast-enhanced appearance in the early period. There was no significant difference in early enhanced rate between endometrial carcinomas and myonletrium of volunteers ( P〉0.05 ) , but there was significant difference between endometrial carcinomas and hysteromyoma ( P〈0.05 ) . There was difference between the study group and control group in intemlediate and late period(30-150) (P〈0.05) . There was maximum difference in late period(120-150s) between endometrial carcinomas and nlyometrium of volunteers, and in early period(20-30s) between endometrial carcinomas and hysteromyoma. In 17 cases with endometrial carcinomas, 15cases had type Ⅰ curve, 2 cases had type Ⅱ. The curves of the control group were almost belong to type Ⅲ, type Ⅳ and type Ⅴ. Conclusins DEC-MRI can reflect the change of blood dynamics of endometrial carcinoma, emphasize observing the signal change and enhanced rate in the early late period(60-150s) with the TIC , that can be useful to diagnose and make stages.
出处 《中国CT和MRI杂志》 2014年第1期89-93,共5页 Chinese Journal of CT and MRI
关键词 子宫内膜癌 磁共振成像 动态增强 时间-信号强度曲线 endometrial carcinoma Magnetic resonance imaging Dynamic contrast-enhanced time-intensity curve
  • 相关文献

参考文献11

  • 1单军,徐坚民,龚静山,王晓玫,徐宏里,冯晓凤.早期增强MRI对良恶性卵巢肿瘤的鉴别诊断价值[J].中华放射学杂志,2003,37(11):1001-1006. 被引量:41
  • 2Scoutt LM; McCarthy SM; FlynnSD, e t a 1. Clinical stagelendometrial carcinoma: pitfallsin preoperative assessment withMR imaging. Work in progress[J].Radiology. 1995. 194 (2): 567-572.
  • 3Youk J H; Son EJ; Chung J,et al. Triple-negativeinvasive breast cancer ondynamic contrast-enhancedand diffusion-weighted MRimaging:comparison with otherbreast cancer subtypes[J]. EurRadiol. 2012. 22 (8): 1724-1734.
  • 4李卫新,詹浩辉,程敬亮.乳腺癌和乳腺纤维腺瘤的DCE-MRI鉴别诊断(附49例分析)[J].中国CT和MRI杂志,2011,9(2):29-31. 被引量:18
  • 5刘彪.卵巢肿瘤良恶性的MRI动态增强鉴别诊断探讨[J].中国CT和MRI杂志,2012,10(4):84-87. 被引量:22
  • 6Coenegraclits K, Van SteenbergenW,De Keyzer, et al.Dynamiccontrast-enhanced MRIof the pancreas: initialresults in healthy volunteersand patients with chronicpancreatitis [J]. Magn ResonImaging. 2004. 20 (6): 990-997.
  • 7Sala E;Crawford R;Senior E,et al. Added value of dynamiccontrast-enhanced magneticresonance imaging in predictingadvanced stage disease inpatients with endometrialca rc i noma [ J]. Int J GynecolCancer. 2009. 19 (1): 141-146.
  • 8袁晓春,张贵祥,何之彦,胡运胜,沈晨.3.0TMRI对早期子宫内膜癌的诊断及分期价值[J].中华放射学杂志,2009,43(5):509-513. 被引量:14
  • 9Sala E; Wakely S; Senior E,et al. MRI of malignantneoplasms of the uterinecorpus and cervix[J]. AJR Am JRoentgenol.2007.188(6):1577-1587.
  • 10Dogan D; I nan N; SarYayci E,et al. Evaluation of depthof myome trial invasion bymagnet ic resonance imagingin patients with endometrialcarcinoma [J].Eur J GynaecolOncol. 2012. 33 (5): 480-484.

二级参考文献30

  • 1单军,王晓玫,徐坚民,马立国,龚静山,凌人男,饶梓彬,冯晓凤,苏学劲.原发卵巢肿瘤MRI早期动态增强表现与CD44v6基因表达[J].中国医学影像技术,2004,20(6):915-918. 被引量:2
  • 2单军,徐坚民,龚静山,王晓玫,徐宏里,冯晓凤.早期增强MRI对良恶性卵巢肿瘤的鉴别诊断价值[J].中华放射学杂志,2003,37(11):1001-1006. 被引量:41
  • 3杨群顶,孙培祥,李向丽,陈桂娥.卵巢囊腺癌的CT诊断[J].中国CT和MRI杂志,2005,3(4):43-45. 被引量:9
  • 4万卫平,施增儒,刘光华,刘仕远,肖湘生.Gd-DTPA在诊断卵巢肿块中的应用及评价[J].中华放射学杂志,1997,31(1):30-34. 被引量:6
  • 5Rockall AG, Meroni G, Sohaib SA, et al. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer,2007,17 : 188-196.
  • 6Chung HH, Kang SB, Cho JY,et al. Accuracy of MR imaging for the predition of myometrial invasion of endometrial carcinoma. Gynecol Oncol,2007,104:654-659.
  • 7Scoutt LM, McCarthy SM, Flynn SD, et al. Clinical stage Ⅰ endometrial carcinoma :pitfalls in preoperative assessement with MR imaging work in progress. Radiology, 1995, 194:562-572.
  • 8Messiou C, Spencer JA, Swift SE, et al. MR staging of endometrial carcinoma. Clin Radiol,2006,61:822-832.
  • 9Koyama T,Tamai K,Togashi K. Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol,2007 ,17 :2009-2019.
  • 10Yamashita Y, Mizutani H, Torashima M, et al. Assessment of myomentrial invasion by endometrial carcinoma: transvaginal sonograghy vs contrast-enchanced MR imaging. AJR, 1993,161 : 595-599.

共引文献89

同被引文献116

  • 1陈宇,吴永彦,张娴,施晓艳.子宫内膜癌18例CT影像学表现[J].贵州医药,2011,35(4):369-370. 被引量:5
  • 2王立侠,欧阳汉.磁共振成像在子宫内膜癌诊断和分期中的应用[J].中国医学影像技术,2004,20(6):967-970. 被引量:23
  • 3高克非,刘富元,冯艳玲,等.子宫颈癌盆腔淋巴结转移的术前CT评价[J].临床肿瘤学杂志,2013,24(12):458-462.
  • 4Sung Bin Park, Min Hoan Moon, Chang Kyu Sung, etal. Dynamic Contrast-Enhanced MR Imaging of Endometrial Cancer: Optimizing the Imaging Delay for Tumour-Myometriunl Contrast[J].European Radiology, 2014, 24 (11):2795-2799.
  • 5Liana S vampane, I l ze Strumfa, Dace Berzina, etal. Epidemiological analysis of hereditary endometrial cancer in a large study population[J]. Archives of Gynecology and Obstetrics, 2014, 289 (5):1093-1099.
  • 6Yang Liu, Weihua Li, Xin Li, etal. Expression and significance of biglycan in endometrial cancer[J].Archives of Gynecology and Obstetrics, 2014, 289 (3):649-655.
  • 7Xueying gang, Aihua Feng, Fengying Liu, etal. CgPl7A1 T-34C polymorphism is not associated with endometrial cancerrisk[J]. Tumor Biology, 2013,34 (5):2583- 2587.
  • 8Humayun A, Khan MS, Haider SA, et al. Endometrial Can- cer and The Role of Statins[J]. N Am J Med Sci, 2015, 7 (12): 577-579.
  • 9Atguden Z, Yildiz A, Aksut H, et al. The Value of Preopera- tive CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer[J]. Asian Pac J Cancer Prev, 2016, 17(2): 497-501.
  • 10Li YT, Lee WL, Tsui KH. Endometrial thickness still pres- ents a best reference to predict endometrial cancer[J]. Tai- wan J Obstet Gynecol, 2016, 55(1): 148-149.

引证文献11

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部